Testing effectiveness (Phase 2)Study completedNCT01876719What this trial is testingAR08 for Treatment of ADHD in ChildrenWho this might be right forADHD Arbor Pharmaceuticals, Inc. 122
Testing effectiveness (Phase 2)Study completedNCT02559570What this trial is testingA Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)Who this might be right forFunctional Constipation in Children Ages 6-17 Years Forest Laboratories 173
Early research (Phase 1)Study completedNCT05034822What this trial is testingStudy of Ruxolitinib Cream in Children With Atopic DermatitisWho this might be right forAtopic Dermatitis Incyte Corporation 29
Large-scale testing (Phase 3)Study completedNCT02052141What this trial is testingSafety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary AngioedemaWho this might be right forHereditary Angioedema (HAE) Shire 12
Large-scale testing (Phase 3)Ended earlyNCT04064827What this trial is testingEvaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)Who this might be right forChronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT) AbbVie 2
Testing effectiveness (Phase 2)Study completedNCT00056381What this trial is testingSafety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17Who this might be right forNeutropenia Pfizer 25